<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2853">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01472835</url>
  </required_header>
  <id_info>
    <org_study_id>NA_00045905</org_study_id>
    <nct_id>NCT01472835</nct_id>
  </id_info>
  <brief_title>Effect of Sedation on Diagnostic Injections</brief_title>
  <official_title>Randomized, Cross-over Study Evaluating the Effect of Sedation on Pain Relief After Diagnostic Injections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Interventional pain procedures have diagnostic, prognostic and therapeutic value. It is
      well-documented that the reference standard for identifying a pain generator is a low-volume
      block performed with local anesthetic, with or without steroid. Many factors may increase
      the false positive (FP) rate of diagnostic and prognostic nerve blocks; however, the use of
      sedation is the most controversial and remediable. Proponents of sedation argue that it has
      little effect on the rate of positive diagnostic blocks, and may even reduce the
      false-negative rate. The purpose of this study is to determine the effect of intravenous
      sedation on pain relief and the &quot;false-positive rate&quot; after diagnostic nerve blocks.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sixty-eight patients with sacroiliac (SI) joint or sympathetically-maintained pain will be
      randomized in a crossover fashion to receive diagnostic nerve blocks either with or without
      intravenous sedation. Among those who obtain some benefit and return for a 2nd block, this
      2nd procedure will be done with sedation if the first was done without sedation, and vice
      versa. Midazolam and fentanyl will be used for intravenous sedation, titrated to anxiolysis
      and analgesia. Pain scores (0-10 numerical rating scale, or NRS) and an activity log will be
      recorded over the 8-hours following the blocks via a pain diary. The first follow-up visit
      will be 4 weeks after the procedure. Patients who obtain some benefit but continue to report
      significant pain or who might otherwise benefit from a repeat procedure will have this
      second procedure performed with sedation if no sedation was given for the first procedure,
      and without sedation if sedation was administered for the first procedure. The
      post-procedure pain data will be recorded in the same fashion as the initial nerve block.
      The second follow-up visit will be 4 weeks after the 2nd block.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">February 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Pain Score</measure>
    <time_frame>through 6 hours after injection</time_frame>
    <safety_issue>No</safety_issue>
    <description>pain diary using 0-10 scale, with 0 being no pain and 10 being the worst pain imaginable</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Score</measure>
    <time_frame>1-month</time_frame>
    <safety_issue>No</safety_issue>
    <description>0-10 numerical rating scale (NRS) pain scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure-related Pain Score</measure>
    <time_frame>1 day</time_frame>
    <safety_issue>No</safety_issue>
    <description>0-10 pain scale, with 0 being no pain and 10 being the worst pain imaginable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oswestry Disability Index</measure>
    <time_frame>1-month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measure of functional capacity on a scale ranging from 0% to 100%, with 0% signifying no disability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction</measure>
    <time_frame>1 day</time_frame>
    <safety_issue>No</safety_issue>
    <description>5-point Likert scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">73</enrollment>
  <condition>Sacroiliac Joint Pain</condition>
  <condition>Sympathetically Maintained Pain</condition>
  <arm_group>
    <arm_group_label>Sedation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pt will receive sedation with their procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patient will not receive sedation during procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>Used for anxiolysis</description>
    <arm_group_label>Sedation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>Used for analgesia and as a sedative</description>
    <arm_group_label>Sedation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic pain &gt; 4 weeks but &lt; 10 years in duration

          -  Suspected SI joint or sympathetically-maintained pain based on history and physical
             exam

          -  May benefit from a sacroiliac joint or sympathetic block

          -  Pain on 0-10 NRS scale &gt; 3/10 in intensity

        Exclusion Criteria:

          -  No previous interventional pain-alleviating injections for the same condition within
             the past 3 years

          -  Uncontrolled coagulopathy

          -  Pregnancy, which will be ruled out by a urine pregnancy test in women of childbearing
             age

          -  Allergy to contrast dye or amide local anesthetics

          -  Unstable medical or psychiatric condition (e.g. unstable angina, congestive heart
             failure or severe depression) that could preclude an optimal treatment response

          -  Systemic infection

          -  Age &lt; 18 or &gt; 75 years
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven P Cohen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Johns Hopkins Blaustein Pain Treatment Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Cohen SP, Hurley RW. The ability of diagnostic spinal injections to predict surgical outcomes. Anesth Analg. 2007 Dec;105(6):1756-75, table of contents. Review.</citation>
    <PMID>18042881</PMID>
  </reference>
  <verification_date>April 2011</verification_date>
  <lastchanged_date>May 19, 2014</lastchanged_date>
  <firstreceived_date>April 25, 2011</firstreceived_date>
  <firstreceived_results_date>March 19, 2014</firstreceived_results_date>
  <responsible_party>
    <name_title>Steven P. Cohen</name_title>
    <organization>Johns Hopkins Medical Institutions</organization>
  </responsible_party>
  <keyword>sedation</keyword>
  <keyword>sensitivity</keyword>
  <keyword>specificity</keyword>
  <keyword>validity</keyword>
  <keyword>diagnostic injection</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Sedation</title>
          <description>Pt will receive sedation with their 1st procedure, then a control procedure will be done without sedation
sacroiliac joint injection: Patient will receive an injection into the sacroiliac joint with bupivacaine and corticosteroid with and without sedation. Since this is a crossover trial, patients will receive both &quot;treatments&quot;.
Sympathetic block: Sympathetic block with bupivacaine
bupivacaine
corticosteroid</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>Patient will not receive sedation during their 1st procedure, but receive sedation during the 2nd procedure</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="36"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
                <participants group_id="P2" count="36"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Sedation</title>
          <description>Pt will receive sedation with their 1st procedure and no sedation with their 2nd procedure
sacroiliac joint injection: Patient will receive an injection into the sacroiliac joint with bupivacaine and corticosteroid with and without sedation. Since this is a crossover trial, patients will receive both &quot;treatments&quot;.
Sympathetic block: Sympathetic block with bupivacaine
bupivacaine
corticosteroid</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>Patient will not receive no sedation during their 1st procedure and sedation during their 2nd procedure</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="37"/>
                <measurement group_id="B2" value="36"/>
                <measurement group_id="B3" value="73"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="49.7" spread="16.1"/>
                <measurement group_id="B2" value="50.3" spread="13.8"/>
                <measurement group_id="B3" value="50.0" spread="15.0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="32"/>
                <measurement group_id="B2" value="35"/>
                <measurement group_id="B3" value="67"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="5"/>
                <measurement group_id="B2" value="1"/>
                <measurement group_id="B3" value="6"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="20"/>
                <measurement group_id="B2" value="22"/>
                <measurement group_id="B3" value="42"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="17"/>
                <measurement group_id="B2" value="14"/>
                <measurement group_id="B3" value="31"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>United States</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="37"/>
                <measurement group_id="B2" value="36"/>
                <measurement group_id="B3" value="73"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pain Score</title>
        <description>pain diary using 0-10 scale, with 0 being no pain and 10 being the worst pain imaginable</description>
        <time_frame>through 6 hours after injection</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Sedation</title>
            <description>Pt will receive sedation with their 1st procedure and no sedation with their 2nd procedure
sacroiliac joint injection: Patient will receive an injection into the sacroiliac joint with bupivacaine and corticosteroid with and without sedation. Since this is a crossover trial, patients will receive both &quot;treatments&quot;.
Sympathetic block: Sympathetic block with bupivacaine
bupivacaine
corticosteroid</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patient will not receive sedation during their 1st procedure but receive sedation during their 2nd procedure</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="36"/>
                  <measurement group_id="O2" value="36"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Pain Score</title>
            <description>pain diary using 0-10 scale, with 0 being no pain and 10 being the worst pain imaginable</description>
            <units>units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="2.2" spread="2.3"/>
                  <measurement group_id="O2" value="3.4" spread="2.8"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Score</title>
        <description>0-10 numerical rating scale (NRS) pain scale</description>
        <time_frame>1-month</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Sedation</title>
            <description>Pt will receive sedation with their procedure
sacroiliac joint injection: Patient will receive an injection into the sacroiliac joint with bupivacaine and corticosteroid with and without sedation. Since this is a crossover trial, patients will receive both &quot;treatments&quot;.
Sympathetic block: Sympathetic block with bupivacaine
bupivacaine
corticosteroid</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patient will not receive sedation during procedure</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="36"/>
                  <measurement group_id="O2" value="36"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Pain Score</title>
            <description>0-10 numerical rating scale (NRS) pain scale</description>
            <units>units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="5.1" spread="2.9"/>
                  <measurement group_id="O2" value="5.6" spread="2.8"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Procedure-related Pain Score</title>
        <description>0-10 pain scale, with 0 being no pain and 10 being the worst pain imaginable</description>
        <time_frame>1 day</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Sedation</title>
            <description>Pt will receive sedation with their 1st procedure and no sedation with their 2nd procedure
sacroiliac joint injection: Patient will receive an injection into the sacroiliac joint with bupivacaine and corticosteroid with and without sedation. Since this is a crossover trial, patients will receive both &quot;treatments&quot;.
Sympathetic block: Sympathetic block with bupivacaine
bupivacaine
corticosteroid</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patient will not receive sedation during the 1st procedure, but receive sedation during their 2nd procedure</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="36"/>
                  <measurement group_id="O2" value="36"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Procedure-related Pain Score</title>
            <description>0-10 pain scale, with 0 being no pain and 10 being the worst pain imaginable</description>
            <units>units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="3.1" spread="2.8"/>
                  <measurement group_id="O2" value="5.5" spread="2.7"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Oswestry Disability Index</title>
        <description>Measure of functional capacity on a scale ranging from 0% to 100%, with 0% signifying no disability</description>
        <time_frame>1-month</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Sedation</title>
            <description>Pt will receive sedation with their procedure
sacroiliac joint injection: Patient will receive an injection into the sacroiliac joint with bupivacaine and corticosteroid with and without sedation. Since this is a crossover trial, patients will receive both &quot;treatments&quot;.
Sympathetic block: Sympathetic block with bupivacaine
bupivacaine
corticosteroid</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patient will not receive sedation during procedure</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="36"/>
                  <measurement group_id="O2" value="36"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Oswestry Disability Index</title>
            <description>Measure of functional capacity on a scale ranging from 0% to 100%, with 0% signifying no disability</description>
            <units>units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="34.8" spread="14.6"/>
                  <measurement group_id="O2" value="40.6" spread="17.9"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Satisfaction</title>
        <description>5-point Likert scale</description>
        <time_frame>1 day</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Sedation</title>
            <description>Pt will receive sedation with their procedure
sacroiliac joint injection: Patient will receive an injection into the sacroiliac joint with bupivacaine and corticosteroid with and without sedation. Since this is a crossover trial, patients will receive both &quot;treatments&quot;.
Sympathetic block: Sympathetic block with bupivacaine
bupivacaine
corticosteroid</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patient will not receive sedation during procedure</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="36"/>
                  <measurement group_id="O2" value="36"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Satisfaction</title>
            <description>5-point Likert scale</description>
            <units>units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="4.0" spread="1.1"/>
                  <measurement group_id="O2" value="3.6" spread="1.4"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 month</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Sedation</title>
          <description>Pt received sedation with their procedure
sacroiliac joint injection: Patient will receive an injection into the sacroiliac joint with bupivacaine and corticosteroid with and without sedation. Since this is a crossover trial, patients will receive both &quot;treatments&quot;.
Sympathetic block: Sympathetic block with bupivacaine
bupivacaine
corticosteroid</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>Patient did not receive sedation during procedure</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <description>Less than 1 day</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="37"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="36"/>
              </event>
              <event>
                <sub_title>dysphagia</sub_title>
                <description>Less than 1 day</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="37"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <description>Less than 1 day</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Worse pain</sub_title>
                <description>Less than 1 week</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <description>Less than 1 day</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="37"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="36"/>
              </event>
              <event>
                <sub_title>Weakness</sub_title>
                <description>Less than 1 day</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Steven Cohen</name_or_title>
      <organization>Johns Hopkins</organization>
      <phone>410-955-1818</phone>
      <email>scohen40@jhmi.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
